Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency, MVK Deficiency (hyperIgD Syndrome)

NCT06497829 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT06497829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency, MVK Deficiency (hyperIgD Syndrome)
Lead sponsor
University Hospital, Motol
Phase
Not applicable
Overall status
Unknown status
Start date
January 25, 2022
Completion date
December 31, 2025
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mevalonate kinase deficiency